Is the Paraquat litigation a class action?

No. Paraquat Parkinson filings are coordinated in MDL 3004 for discovery efficiency, but they are not a class action where one judgment binds everyone. Compensation discussions still turn on each person’s spray history, PD onset, and expert proof.

Who may qualify for a Paraquat lawsuit?

Individuals who were exposed to Paraquat through work (agriculture, landscaping, pesticide application) or living near treated areas and were later diagnosed with Parkinson's disease may be candidates for a free case review. Exposure must have occurred before diagnosis. A free review can help determine whether your information may be shared with an independent law firm.

What is the Paraquat MDL and where is it?

The Paraquat MDL is In re: Paraquat Products Liability Litigation, MDL No. 3004, in the Southern District of Illinois, before Judge Nancy J. Rosenstengel. It centralizes federal lawsuits for coordinated discovery and pretrial rulings while each case remains individual.

What are the key upcoming dates?

Global settlement negotiations are underway; court deadlines have been repeatedly extended as parties work toward resolution. Bellwether trials originally set for 2025–2026 were paused during settlement talks. Check our hub for the latest updates.

What does the science say about Paraquat and Parkinson's?

Multiple peer-reviewed studies (including the NIH-funded Agricultural Health Study, UCLA environmental health research, and meta-analyses) have found that Paraquat exposure is associated with a significantly elevated risk of Parkinson's disease—in some studies up to 2.5 times higher for exposed individuals. Researchers have identified mechanisms by which Paraquat may damage dopamine-producing neurons.

How do I get a free case review?

You can start a free, confidential case review on our Paraquat lawsuit page. There is no cost or obligation. If appropriate, we may share your information with an independent law firm for evaluation.

TOP TIERLegal

Back to Paraquat Lawsuit

Paraquat Lawsuit News & Updates

Parkinson’s diagnoses following Paraquat exposure are litigated chiefly through MDL 3004 in southern Illinois. We distill scheduling orders, science disputes, and exposure fact patterns so applicators and neighbors can orient quickly—nothing here forms an attorney-client relationship.

Last updated: June 8, 2026

Paraquat Litigation at a Glance

MDL

No. 3004 (S.D. Ill.)

Presiding Judge

Hon. Nancy J. Rosenstengel

Pending Cases

6,400+ pending

Next Key Date

Settlement negotiations ongoing; deadlines extended

Latest Paraquat Lawsuit Update

The latest MDL 3004 activity centers on expert discovery, Daubert rulings, and bellwether selections while global settlement talks continue.

Each Parkinson's plaintiff must still prove personal exposure and medical causation. Bellwether cases signal which fact patterns the court views as representative—not guaranteed outcomes for other filers.

Current Paraquat Lawsuit News

•Over 6,400 lawsuits pending in the Paraquat MDL before Judge Nancy J. Rosenstengel in the Southern District of Illinois
•Global settlement negotiations underway; payout details being finalized
•Bellwether trials originally set for 2025–2026; some paused during settlement talks
•Court deadlines repeatedly extended as parties work toward resolution
•Syngenta, Chevron, and other manufacturers face claims alleging failure to warn about Parkinson's risk

Video Update: Paraquat Settlement Deadlines

Urgent Paraquat Parkinson's Update: Deadlines Are Narrowing for Parkinson's Settlements

The MDL settlement window is narrowing. Watch this update for the latest on filing deadlines, what the ongoing negotiations mean for claimants, and why acting now matters.

Watch on YouTube

This video is for informational purposes only and does not constitute legal advice.

Legal Case Updates: MDL and Paraquat Litigation

Paraquat cases are centralized in MDL No. 3004 in the Southern District of Illinois—not a class action where one verdict binds everyone.

Judge Nancy J. Rosenstengel oversees coordinated discovery and bellwether planning. Plaintiffs allege Syngenta, Chevron, and other manufacturers knew of a Paraquat–Parkinson's link but failed to warn users adequately.

Why This Isn't a Paraquat Class Action

No—this is an MDL, not a class action: each plaintiff keeps an individual case and any recovery depends on that person's injuries and proof.

In a class action, one outcome would apply to the whole group. The MDL structure typically allows damages to reflect each plaintiff's severity rather than a single shared award.

Key Dates and Legal Developments

Date / Period	Development
June 2021	Judicial Panel on Multidistrict Litigation consolidates federal Paraquat cases into MDL No. 3004 in the Southern District of Illinois.
2022–2024	Discovery, bellwether selection, and scientific evidence proceedings. Case count grows to thousands.
2025–2026	Global settlement negotiations underway; bellwether trials paused. Court deadlines repeatedly extended. Over 6,400 cases pending.
Ongoing	New Paraquat injury claims continue to be filed; state court cases proceed in parallel where applicable.

Science & Evidence Behind the Claims

Peer-reviewed research has established a connection between Paraquat exposure and an increased risk of Parkinson's disease. Courts and plaintiffs rely on this body of evidence when evaluating failure-to-warn and causation. Key studies include:

Agricultural Health Study (AHS)

The NIH-funded Agricultural Health Study followed tens of thousands of farmers and pesticide applicators. Analyses found that individuals who used Paraquat had a significantly elevated risk of developing Parkinson's disease—with risk estimates ranging from about 1.5x to 2.5x higher depending on exposure levels.

UCLA / Environmental Health Studies

UCLA researchers and others have published studies showing that Paraquat exposure is associated with oxidative stress and damage to dopaminergic neurons—the same cells affected in Parkinson's disease. Combined exposure to Paraquat and certain other pesticides may further increase risk.

Meta-Analyses and Systematic Reviews

Meta-analyses pooling data from multiple studies have consistently found an association between Paraquat exposure and Parkinson's disease risk. These analyses strengthen the scientific basis for litigation claims that manufacturers knew or should have known about the risks.

For a deeper dive, read Paraquat Parkinson's Lawsuit: Science, Exposure & Legal Claims and Paraquat and Parkinson's Disease.

Think You May Qualify?

If you were exposed to Paraquat and were diagnosed with Parkinson's disease, you may be eligible for a free case review. Get the full picture on eligibility, settlement tiers, and how to get connected with a law firm.

Paraquat Lawsuit – Free Case Review

Frequently Asked Questions

Ready to See If You Qualify?

Free, confidential case review. No obligation. We may connect you with an independent law firm if appropriate.

Start Free Case Review

Disclaimer

This Paraquat lawsuit news page is for informational purposes only and does not constitute legal advice. Top Tier Legal LLC is not a law firm. Litigation status and dates may change. For the most current Paraquat lawsuit update and to see if you qualify for a free case review, visit our Paraquat lawsuit page or contact us.